Corrigendum to: Repair of Critical-Sized Rat Calvarial Defects Using Genetically Engineered Bone Marrow-Derived Mesenchymal Stem Cells Overexpressing Hypoxia-Inducible Factor-1α (STEM CELLS, (2011), 29, 9, (1380-1390), 10.1002/stem.693);Repair of critical-sized rat calvarial defects using genetically engineered bone marrow-derived mesenchymal stem cells overexpressing hypoxia-inducible factor-1α

Stem Cells

Volumn 29, Issue 9, 2011, Pages 1380-1390

  Zou, Duohong ^a,b,f   Zhang, Zhiyuan ^b   Ye, Dongxia ^b   Tang, Aifa ^c   Deng, Lianfu ^d   Han, Wei ^e   Zhao, Jun ^b   Wang, Shuhong ^a   Zhang, Wenjie ^b   Zhu, Chao ^b   Zhou, Jian ^f   He, Jiacai ^f   Wang, Yuanyin ^f   Xu, Feng ^b   Huang, Yuanliang ^a   Jiang, Xinquan ^b  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^e Jiangsu Province Engineering Research Center of Stomatological Translational Medicine   (China)

^f ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow derived mesenchymal stem cells; Bone regeneration; Gene therapy; Hypoxia inducible factor 1 ; Osteogenesis

Indexed keywords

ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LENTIVIRUS VECTOR; MESSENGER RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE DENSITY; BONE DEVELOPMENT; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELL; MALE; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; SKULL DEFECT; WILD TYPE;

LENTIVIRUS; RATTUS;

EID: 80051993827     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.3459     Document Type: Erratum

References (34)

1. Bruder S.P., Kurth A.A., Shea M. et al. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-162. (Pubitemid 28249153)
2. Zhao Z., Wang Z., Ge C. et al. Healing cranial defects with AdRunx2-transduced marrow stromal cells. J Dent Res 2007;86:1207-1211.
3. Wang Y., Wan C., Deng L. et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007;117:1616-1626. (Pubitemid 46871346)
4. Wiesener M.S., Turley H., Allen W.E. et al. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1alpha. Blood 1998;92:2260-2268. (Pubitemid 28452966)
5. Park S.K., Dadak A.M., Haase V.H. et al. Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): Role of cytoplasmic trapping of HIF-2alpha. Mol Cell Biol 2003;23:4959-4971. (Pubitemid 36793341)
6. Scortegagna M., Ding K., Oktay Y. et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet 2003;35:331-340. (Pubitemid 37486916)
7. Weidemann A., Johnson R.S. Biology of HIF-1alpha. Cell Death Differ 2008;15:621-627.
8. Sarkar K., Fox-Talbot K., Steenbergen C. et al. Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci USA 2009;106:18769-1874.
9. Mahon P.C., Hirota K., Semenza G.L. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001;15:2675-2686. (Pubitemid 32988878)
10. Jaakkola P., Mole D.R., Tian Y.M. et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468-472. (Pubitemid 32335942)
11. Bruder S.P., Fox B.S. Tissue engineering of bone. Cell based strategies. Clin Orthop Relat Res 1999;S68-S83. (Pubitemid 29501488)
12. Liechty K.W., MacKenzie T.C., Shaaban A.F. et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282-1286.
13. Tsuda H., Wada T., Ito Y. et al. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 2003;7:354-365. (Pubitemid 36503859)
14. Zhang C., Wang K.Z., Qiang H. et al. Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo. Acta Pharmacol Sin 2010;31:821-830.
15. Maniatopoulos C., Sodek J., Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988;254:317-330.
16. Li Y, Liu X, Liu C et al. Improvement of morphine-mediated analgesia by inhibition of beta-arrestin 2 expression in mice periaqueductal gray matter. Int J Mol Sci 2009;3:954-63.
17. Jing Q., Xin S.M., Cheng Z.J. et al. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: Mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity. Circ Res 1999;84:831-839. (Pubitemid 29181490)
18. Kasten P., Luginbuhl R, van GM, et al. Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix. Biomaterials 2003;24:2593-2603. (Pubitemid 36506482)
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408. (Pubitemid 34164012)
20. Koh J.T., Zhao Z., Wang Z. et al. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. J Dent Res 2008;87:845-849.
21. Mardas N., Stavropoulos A., Karring T. Calvarial bone regeneration by a combination of natural anorganic bovine-derived hydroxyapatite matrix coupled with a synthetic cell-binding peptide (PepGen): An experimental study in rats. Clin Oral Implants Res 2008;19:1010-1015.
22. Bolland B.J., Kanczler J.M., Dunlop D.G. et al. Development of in vivo muCT evaluation of neovascularisation in tissue engineered bone constructs. Bone 2008;43:195-202.
23. Cacciafesta V., Dalstra M., Bosch C. et al. Growth hormone treatment promotes guided bone regeneration in rat calvarial defects. Eur J Orthod 2001;23:733-740. (Pubitemid 33672026)
24. Sun X.J., Zhang Z.Y., Wang S.Y. et al. Maxillary sinus floor elevation using a tissue-engineered bone complex with OsteoBone and bMSCs in rabbits. Clin Oral Implants Res 2008;19:804-813.
25. Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010;40:294-309.
26. Kelly B.D., Hackett S.F., Hirota K. et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003;93:1074-1081. (Pubitemid 37485038)
27. Manalo D.J., Rowan A., Lavoie T. et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005;105:659-669. (Pubitemid 40070750)
28. Jiang X., Gittens S.A., Chang Q. et al. The use of tissue-engineered bone with human bone morphogenetic protein-4-modified bone-marrow stromal cells in repairing mandibular defects in rabbits. Int J Oral Maxillofac Surg 2006;35:1133-1139. (Pubitemid 44718377)
29. Riley E.H., Lane J.M., Urist M.R. et al. Bone morphogenetic protein-2: Biology and applications. Clin Orthop Relat Res 1996;324:39-46. (Pubitemid 26071749)
30. Grayson W.L., Zhao F., Izadpanah R. et al. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 2006;207:331-339.
31. Rohanizadeh R., Swain M.V., Mason R.S. Gelatin sponges (Gelfoam) as a scaffold for osteoblasts. J Mater Sci Mater Med 2008;19:1173-1182. (Pubitemid 351337473)
32. Rey S., Lee K., Wang C.J. et al. Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc Natl Acad Sci USA 2009;106:20399-20404.
33. Wan C., Shao J., Gilbert S.R. et al. Role of HIF-1alpha in skeletal development. Ann N Y Acad Sci 2010;1192:322-326.
34. Liu L., Marti G.P., Wei X. et al. Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells. J Cell Physiol 2008;217:319-327.